Neuromuscular Disorders

Emflaza approved by FDA for Duchenne muscular dystrophy

Emflaza approved by FDA for Duchenne muscular dystrophy

The corticosteroid was approved to treat Duchenne muscular dystrophy in patients 5 years and older.

Sign Up for Free e-newsletters